RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates

  • Andreas Pichlmair
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Oliver Schulz
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Choon Ping Tan
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Tanja I. Näslund
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Peter Liljeström
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Friedemann Weber
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
  • Caetano Reis e Sousa
    Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.

抄録

<jats:p>Double-stranded RNA (dsRNA) produced during viral replication is believed to be the critical trigger for activation of antiviral immunity mediated by the RNA helicase enzymes retinoic acid–inducible gene I (RIG-I) and melanoma differentiation–associated gene 5 (MDA5). We showed that influenza A virus infection does not generate dsRNA and that RIG-I is activated by viral genomic single-stranded RNA (ssRNA) bearing 5′-phosphates. This is blocked by the influenza protein nonstructured protein 1 (NS1), which is found in a complex with RIG-I in infected cells. These results identify RIG-I as a ssRNA sensor and potential target of viral immune evasion and suggest that its ability to sense 5'-phosphorylated RNA evolved in the innate immune system as a means of discriminating between self and nonself.</jats:p>

収録刊行物

  • Science

    Science 314 (5801), 997-1001, 2006-11-10

    American Association for the Advancement of Science (AAAS)

被引用文献 (89)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ